⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ELOX News
Eloxx Pharmaceuticals, Inc. Common Stock
Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
prnewswire.com
ELOX
Alport Syndrome Report Outlook Report 2026-2036: Review Pricing, Reimbursement, Market Access and Drug Uptake Considerations
globenewswire.com
ELOX
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
prnewswire.com
ELOX
Form 8-K
sec.gov
ELOX
Life Biosciences Appoints Stephen Webster to Board of Directors
globenewswire.com
JNJ
MRK
ELOX
Alport Syndrome Market to Grow at a Tremendous 47% CAGR Through 2036, Driven by Emerging Therapies and Expanding Clinical Pipeline | DelveInsight
prnewswire.com
ELOX
EVTC
NVS
TARA
Form 8-K
sec.gov
ELOX
Form 8-K
sec.gov
ELOX